Рандомизированное контролируемое исследование III фазы с целью сравнительной оценки пакритиниба и препарата по выбору врача при лечении пациентов с первичным миелофиброзом или миелофиброзом, развившимся после истинной полицитемии либо эссенциальной тромбоцитемии, у которых имеется тяжелая тромбоцитопения (уровень тромбоцитов <50 000/мкл)".
Клинические исследования и проекты
Шымкент · идёт · найдено 5
Assessment of the Clinical Profile of Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in the Republic of Kazakhstan and the Clinical Effectiveness of UDCA (Ursosan®) in the Patient Population of Almaty: A Longitudinal Observational Combined Study With Cross-Sectional and Prospective Cohort Components
Evaluation of Clinical Effectiveness in Real-World Clinical Practice, as Well as the Safety and Adherence to Therapy With a Fixed-Dose Combination of Amlodipine and Valsartan
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of 3 Active Dose Regimens of MORF-057 in Adults With Moderately to Severely Active Crohn's Disease (GARNET)
Multicenter, Observational, Descriptive Study of the Diagnosis, Course and Treatment of Patients With SLE in Routine Practice in Kazakhstan: a Registry Study With Retrospective and Prospective Components.